Poolbeg Pharma (POLB), a clinical-stage infectious disease pharmaceutical company, said that AI partner OneThree Biotech, Inc., has completed the build and optimisation of a tailored AI model of Poolbeg’s RSV
What a week across the oil & gas sector, news due next week on CLON, ANGS is within touching distance and Share Talk is looking to talk to both companies, plus
Pensana (PRE) said it has completed a Front End Engineering Design and Value Engineering Study into establishing a UK-based supply of the magnet metal rare earths vital for the electric
ImmuPharma PLC (LSE:IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company, is pleased to announce its final results for the twelve months ended 31 December 2021 (the
Open Orphan (ORPH), a specialist contract research organisation said it noted market speculation regarding a potential delisting. The company confirmed that it has no plans to delist and is working
Share Talk are proud to be hosting the Pantheon Resources Plc – Shareholder Presentation and Q&A – Tuesday, April 26, 2022, at 5:30 PM BST.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Altus, Angus, Cobra, East Star, Galileo,
Data confirms positive readout from P140 PK study
Open Orphan (ORPH), a specialist contract research organisation, noted the announcement from Poolbeg Pharma (POLB), regarding a number of new investors having expressed interest in acquiring up to £1.6m of
Zak Mir delivers a charting take on some of the most followed stocks on the London market. Today’s selection includes African, Ferro, Hemo, i3, ImmuPharma, Nanosynth, Rua, THG, United Oil
Zak Mir takes a look at some of the most followed small caps on the London market. Today’s selection includes Alpha Growth, Bens Creek Group, Feedback, Gunsynd, ImmuPharma, Powerhouse, Rambler
